The experimental autoimmune encephalomyelitis disease course is modulated by nicotine and other cigarette smoke components

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Gao, Zhen ^a   Nissen, Jillian C ^a   Ji, Kyungmin ^a   Tsirka, Stella E ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACROLEIN; CIGARETTE SMOKE; CIGARETTE SMOKE CONDENSATE; NICOTINE; NICOTINE TARTRATE; ANTIINFLAMMATORY AGENT; PEPTIDE; SMOKE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL SUBPOPULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; DRUG RESPONSE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; MICROGLIA; MOLECULAR PATHOLOGY; MOUSE; NEWBORN; NONHUMAN; WEIGHT GAIN; ADVERSE EFFECTS; ANALYSIS; ANIMAL; C57BL MOUSE; CELL CULTURE; CHEMICALLY INDUCED; CHEMISTRY; DEMYELINATING DISEASES; DISEASE MODEL; DRUG EFFECTS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMAN; MULTIPLE SCLEROSIS; PATHOLOGY; SMOKE; SMOKING; TOBACCO;

ACROLEIN; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELLS, CULTURED; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HUMANS; MICE, INBRED C57BL; MICROGLIA; MULTIPLE SCLEROSIS; NICOTINE; PEPTIDES; SMOKE; SMOKING; TOBACCO;

EID: 84907457604     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107979     Document Type: Article

References (60)

1. Handel AE, Williamson AJ, Disanto G, Dobson R, Giovannoni G, et al. (2011) Smoking and multiple sclerosis: an updated meta-analysis. PLoS One 6: e16149.
2. Hernan MA, Olek MJ, Ascherio A (2001) Cigarette smoking and incidence of multiple sclerosis. Am J Epidemiol 154: 69-74.
3. Pittas F, Ponsonby A, van der Mei I, Taylor B, Blizzard L, et al. (2009) Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis. J Neurol 256: 577-585.
4. Sundstrom P, Nystrom L (2008) Smoking worsens the prognosis in multiple sclerosis. Mult Scler 14: 1031-1035.
5. Rowland LM, Beason-Held L, Tamminga CA, Holcomb HH (2010) The interactive effects of ketamine and nicotine on human cerebral blood flow. Psychopharmacology (Berl) 208: 575-584.
6. Hawkins BT, Abbruscato TJ, Egleton RD, Brown RC, Huber JD, et al. (2004) Nicotine increases in vivo blood-brain barrier permeability and alters cerebral microvascular tight junction protein distribution. Brain Res 1027: 48-58.
7. de Vries HE, Kooij G, Frenkel D, Georgopoulos S, Monsonego A, et al. (2012) Inflammatory events at blood-brain barrier in neuroinflammatory and neurodegenerative disorders: implications for clinical disease. Epilepsia 53 Suppl 6: 45-52.
8. Razani-Boroujerdi S, Boyd R, Davila-Garcia M, Nandi J, Mishra N, et al. (2007) T cells express alpha7-nicotinic acetylcholine receptor subunits that require a functional TCR and leukocyte-specific protein tyrosine kinase for nicotineinduced Ca2+ response. J Immunol 179: 2889-2898.
9. Wang H, Yu M, Ochani M, Amella C, Tanovic M, et al. (2003) Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421: 384-388.
10. Jin H, Li H, Sui H, Xue M, Wang Y, et al. (2012) Nicotine stimulated bone marrow-derived dendritic cells could augment HBV specific CTL priming by activating PI3K-Akt pathway. Immunol Lett 146: 40-49.
11. Shi FD, Piao WH, Kuo YP, Campagnolo DI, Vollmer TL, et al. (2009) Nicotinic attenuation of central nervous system inflammation and autoimmunity. J Immunol 182: 1730-1739.
12. Carlens C, Hergens MP, Grunewald J, Ekbom A, Eklund A, et al. (2010) Smoking, use of moist snuff, and risk of chronic inflammatory diseases. Am J Respir Crit Care Med 181: 1217-1222.
13. Hedstrom AK, Baarnhielm M, Olsson T, Alfredsson L (2009) Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis. Neurology 73: 696-701.
14. van Noort J, van den Elsen P, van Horssen J, Geurts J, van der Valk P, et al. (2011) Preactive multiple sclerosis lesions offer novel clues for neuroprotective therapeutic strategies. CNS Neurol Disord Drug Targets 10: 68-81.
15. Zhang Z, Zhang ZY, Schittenhelm J, Wu Y, Meyermann R, et al. (2011) Parenchymal accumulation of CD163(+) macrophages/microglia in multiple sclerosis brains. J Neuroimmunol 237: 73-79.
16. Mikita J, Dubourdieu-Cassagno N, Deloire MS, Vekris A, Biran M, et al. (2011) Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of Multiple Sclerosis. Amelioration of clinical status by M2 activated monocyte administration. Mult Scler 17: 2-15.
17. Bhasin M, Wu M, Tsirka SE (2007) Modulation of microglial/macrophage activation by macrophage inhibitory factor (TKP) or tuftsin (TKPR) attenuates the disease course of experimental autoimmune encephalomyelitis. BMC Immunol 8, 10.
18. Defaux A, Zurich MG, Honegger P, Monnet-Tschudi F (2011) Minocycline promotes remyelination in aggregating rat brain cell cultures after interferongamma plus lipopolysaccharide-induced demyelination. Neuroscience.
19. Rasmussen S, Imitola J, Ayuso-Sacido A, Wang Y, Starossom SC, et al. (2011) Reversible neural stem cell niche dysfunction in a model of multiple sclerosis. Ann Neurol 69: 878-891.
20. Wu M, Nissen JC, Chen EI, Tsirka SE (2012) Tuftsin promotes an antiinflammatory switch and attenuates symptoms in experimental autoimmune encephalomyelitis. PLoS One 7: e34933.
21. Matta SG, Balfour DJ, Benowitz NL, Boyd RT, Buccafusco JJ, et al. (2007) Guidelines on nicotine dose selection for in vivo research. Psychopharmacology (Berl) 190: 269-319.
22. Wu M, Tsirka S (2009) Endothelial NOS-deficient mice reveal dual roles for nitric oxide during experimental autoimmune encephalomyelitis. Glia 57: 1204-1215.
23. Benowitz NL (1996) Biomarkers of Cigarette Smoking. In: National Cancer Institute (U.S.). The FTC cigarette test method for determining tar n, and carbon monoxide yields of US cigarettes: report of the NCI Expert Committee., editor. Smoking and tobacco control monograph. Bethesda, MD: NIH (NIH Publication No 96-4028). pp. 93-111.
24. Paulson JR, Yang T, Selvaraj PK, Mdzinarishvili A, Van der Schyf CJ, et al. (2010) Nicotine exacerbates brain edema during in vitro and in vivo focal ischemic conditions. J Pharmacol Exp Ther 332: 371-379.
25. Matsuda R, Kezuka T, Nishiyama C, Usui Y, Matsunaga Y, et al. (2012) Suppression of murine experimental autoimmune optic neuritis by mature dendritic cells transfected with calcitonin gene-related Peptide gene. Invest Ophthalmol Vis Sci 53: 5475-5485.
26. Rogove A, Tsirka S (1998) Neurotoxic responses by microglia elicited by excitotoxic injury in the mouse hippocampus. Curr Biol 8: 19-25.
27. Zhai H, Heppner F, Tsirka S (2011) Microglia/macrophages promote glioma progression. Glia 59: 472-485.
28. Zhang W, Fang M, Song F, Windsor LJ (2011) Effects of cigarette smoke condensate and nicotine on human gingival fibroblast-mediated collagen degradation. J Periodontol 82: 1071-1079.
29. Hao J, Simard AR, Turner GH, Wu J, Whiteaker P, et al. (2011) Attenuation of CNS inflammatory responses by nicotine involves alpha7 and non-alpha7 nicotinic receptors. Exp Neurol 227: 110-119.
30. Murphy AC, Lalor SJ, Lynch MA, Mills KH (2010) Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis. Brain Behav Immun 24: 641-651.
31. Leung G, Sun W, Zheng L, Brookes S, Tully M, et al. (2011) Anti-acrolein treatment improves behavioral outcome and alleviates myelin damage in experimental autoimmune encephalomyelitis mouse. Neuroscience 173: 150-155.
32. Chen J, Higby R, Tian D, Tan D, Johnson MD, et al. (2008) Toxicological analysis of low-nicotine and nicotine-free cigarettes. Toxicology 249: 194-203.
33. Caito S, Rajendrasozhan S, Cook S, Chung S, Yao H, et al. (2010) SIRT1 is a redox-sensitive deacetylase that is post-translationally modified by oxidants and carbonyl stress. FASEB J 24: 3145-3159.
34. Roemer E, Schramke H, Weiler H, Buettner A, Kausche S, et al. (2012) Mainstream Smoke Chemistry and In Vitro and In Vivo Toxicity of the Reference Cigarettes 3R4F and 2R4F. Beitr Tabakforsch Int 25: 316-335.
35. Intorp M, Purkis S, Wagstaff W (2012) Determination of Carbonyl compounds in cigarette mainstream smoke. The CORESTA 2010 collaborative study and recommended method. Beitr Tabakforsch Int 25: 361-374.
36. Liu-Snyder P, Borgens RB, Shi R (2006) Hydralazine rescues PC12 cells from acrolein-mediated death. J Neurosci Res 84: 219-227.
37. Burcham P, Pyke S (2006) Hydralazine Inhibits Rapid Acrolein-Induced Protein Oligomerization: Role of Aldehyde Scavenging and Adduct Trapping in Cross-Link Blocking and Cytoprotection. Mol Pharmacol 69: 1056-1065.
38. Centonze D, Muzio L, Rossi S, Cavasinni F, De Chiara V, et al. (2009) Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis. J Neurosci 29: 3442-3452.
39. Pitt D, Werner P, Raine C (2000) Glutamate excitotoxicity in a model of multiple sclerosis. Nature Med 6: 67-70.
40. Salzer J, Hallmans G, Nystrom M, Stenlund H, Wadell G, et al. (2012) Smoking as a risk factor for multiple sclerosis. Mult Scler.
41. Cloez-Tayarani I, Changeux JP (2007) Nicotine and serotonin in immune regulation and inflammatory processes: A perspective. J Leukoc Biol 81: 599-606.
42. Rogers SW, Gregori NZ, Carlson N, Gahring LC, Noble M (2001) Neuronal nicotinic acetylcholine receptor expression by O2A/oligodendrocyte progenitor cells. Glia 33: 306-313.
43. Pillai S, Chellappan S (2012) alpha7 nicotinic acetylcholine receptor subunit in angiogenesis and epithelial to mesenchymal transition. Curr Drug Targets 13: 671-679.
44. Fletcher JM, Lalor SJ, Sweeney CM, Tubridy N, Mills KH (2010) T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol 162: 1-11.
45. Nizri E, Irony-Tur-Sinai M, Lory O, Orr-Urtreger A, Lavi E, et al. (2009) Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses. J Immunol 183: 6681-6688.
46. Becher B, Bechmann I, Greter M (2006) Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain. J Mol Med 84: 532-543.
47. Li WW, Setzu A, Zhao C, Franklin RJ (2005) Minocycline-mediated inhibition of microglia activation impairs oligodendrocyte progenitor cell responses and remyelination in a non-immune model of demyelination. J Neuroimmunol 158: 58-66.
48. Butovsky O, Landa G, Kunis G, Ziv Y, Avidan H, et al. (2006) Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis. J Clin Invest 116: 905-915.
49. Butovsky O, Ziv Y, Schwartz A, Landa G, Talpalar A, et al. (2006) Microglia activated by IL-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Mol Cell Neurosci 31: 149-160.
50. Moon JH, Kim SY, Lee HG, Kim SU, Lee YB (2008) Activation of nicotinic acetylcholine receptor prevents the production of reactive oxygen species in fibrillar beta amyloid peptide (1-42)-stimulated microglia. Exp Mol Med 40: 11-18.
51. Suzuki T, Hide I, Matsubara A, Hama C, Harada K, et al. (2006) Microglial alpha7 nicotinic acetylcholine receptors drive a phospholipase C/IP3 pathway and modulate the cell activation toward a neuroprotective role. J Neurosci Res 83: 1461-1470.
52. Ohnishi M, Katsuki H, Takagi M, Kume T, Akaike A (2009) Long-term treatment with nicotine suppresses neurotoxicity of, and microglial activation by, thrombin in cortico-striatal slice cultures. Eur J Pharmacol 602: 288-293.
53. Orr-Urtreger A, Kedmi M, Rosner S, Karmeli F, Rachmilewitz D (2005) Increased severity of experimental colitis in alpha 5 nicotinic acetylcholine receptor subunit-deficient mice. Neuroreport 16: 1123-1127.
54. Wickenden JA, Clarke MC, Rossi AG, Rahman I, Faux SP, et al. (2003) Cigarette smoke prevents apoptosis through inhibition of caspase activation and induces necrosis. Am J Respir Cell Mol Biol 29: 562-570.
55. Shaked I, Porat Z, Gersner R, Kipnis J, Schwartz M (2004) Early activation of microglia as antigen-presenting cells correlates with T cell-mediated protection and repair of the injured central nervous system. J Neuroimmunol 146: 84.
56. Liu J, Liang Q, Frost-Pineda K, Muhammad-Kah R, Rimmer L, et al. (2011) Relationship between biomarkers of cigarette smoke exposure and biomarkers of inflammation, oxidative stress, and platelet activation in adult cigarette smokers. Cancer Epidemiol Biomarkers Prev 20: 1760-1769.
57. Momi N, Ponnusamy M, Kaur S, Rachagani S, Kunigal S, et al. (2013) Nicotine/cigarette smoke promotes metastasis of pancreatic cancer through alpha7nAChR-mediated MUC4 upregulation. Oncogene 32: 1384-1395.
58. Warren G, Singh A (2013) Nicotine and lung cancer. J Carcinog 12: 1.
59. Odoardi F, Sie C, Streyl K, Ulaganathan VK, Schlager C, et al. (2012) T cells become licensed in the lung to enter the central nervous system. Nature 488: 675-679.
60. Mehra D, Geraghty PM, Hardigan AA, Foronjy R (2012) A comparison of the inflammatory and proteolytic effects of dung biomass and cigarette smoke exposure in the lung. PLoS One 7: e52889.